首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1550160

多組體學全球市場

Global Multiomics Market

出版日期: 2024年09月06日 | 出版商:

BCC Research | 英文 149 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球多組體學市場規模預計將從 2024 年的 27 億美元增至 2029年終的 51 億美元，預測期內複合年成長率為 13.5%。

消耗品產業預計將從 2024 年的 16 億美元成長到 2029年終的31 億美元，複合年成長率為 14.1%。此外，設備領域預計將從 2024 年的 6.299 億美元成長到 2029 年底的11 億美元，複合年成長率為 12.4%。

本報告調查了全球多組體學市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測，以及各個細分市場和地區。我們總結了主要企業的詳細分析、競爭格局、概況等。

市場動態
市場促進因素
多組體學研究及其應用的快速進展
多組體學研究的有利資金籌措方案
DNA定序價格下降
癌症發生率的增加增加了對個人化治療的需求
多組體學在藥物開發過程中的應用前景
市場限制因素
缺乏資料標準化
市場機會
擴展單細胞多組體學應用

第4章新興科技與發展

多組體學中的人工智慧
人工智慧多組體學市場的公司
單體學和多組體學的進展

第5章市場區隔分析

主要市場趨勢
細分細分
全球多組體學市場：按產品
裝置
消耗品
軟體和服務
全球多組體學市場：按平台
基因組學
蛋白質體學
轉錄組學
代謝體學
其他
全球多組體學市場：依應用分類
瘤
免疫
神經
細胞生物學
其他
全球多組體學市場：依最終用戶分類
學術研究所
製藥和生物技術公司
臨床實驗室/院內實驗室
其他
地域分佈
全球多組體學市場：按地區
北美洲
歐洲
亞太地區
其他領域

第6章競爭訊息

主要企業排名
企業招募策略
協作與夥伴關係
新產品發布
擴張和投資
M&A
協定
專利分析

第 7 章多組體學市場的永續性：ESG 視角

ESG：簡介
市場ESG表現
多組體學產業的 ESG 實踐
BCC 的結論

第8章附錄

調查方法
縮寫詞
參考
公司簡介
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BD
BRUKER
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

Product Code: BIO260A

The global market for multiomics is expected to grow from $2.7 billion in 2024 and is projected to reach $5.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.

The global market for multiomics for consumables is expected to grow from $1.6 billion in 2024 and is projected to reach $3.1 billion by the end of 2029, at a CAGR of 14.1% during the forecast period of 2024 to 2029.

The global market for multiomics for instruments is expected to grow from $629.9 million in 2024 and is projected to reach $1.1 billion by the end of 2029, at a CAGR of 12.4% during the forecast period of 2024 to 2029.

Report Scope:

This report covers the global market for multiomics segments based on products, platforms, applications, end-users, and regions. This research report incorporates an in-depth analysis of the multiomics market, including market estimations and trends through 2029. By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.

Major players, products, platforms, applications, market dynamics, and geographic opportunities are discussed in detail in the report. This report also examines various analytical frameworks such as PESTEL analysis, ESG analysis, competitive analysis, and strategic recommendations, which will aid the companies in devising their strategic plan of action.

Report Includes:

51 data tables and 55 additional tables
An analysis of the current and future global markets for multiomics
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global multiomics market, with market share analysis by product, type, platform, end-user, application and region
Discussion of the applications of multiomics in research studies such as analyzing many omics datasets, integrating data from genomes, transcriptomics, epigenetics, and proteomics. This in turn provides more precise information to identify causal alterations, and by exposing the etiology of the disease, can lead to the possible treatment options
Discussions of the market dynamics, opportunities, and challenges, as well as emerging technologies
Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies' market shares, recent M&A activity, and venture funding.
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., and F. Hoffman-La Roche Ltd.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Technology Background
Omics Types
Various Multiomics Approaches and Applications
Technological Infrastructure and Data Integration
PESTEL Analysis
Political
Economic
Social
Technological
Environmental
Legal
Regulatory Landscape
Federal Regulation
CMS Regulation
U.S. Food and Drug Administration Regulation
U.S. Federal Trade Commission Regulation
Strategic Recommendations

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Rapid Advances in Multiomics Research and its Applications
Favorable Funding Scenario for Multiomics Research Activities
Decrease in DNA-Sequencing Method Prices
Growing Prevalence of Cancer Generating Demand for Personalized Treatments
Promising Applications of Multiomics in the Drug Development Process
Market Restraints
Lack of Data Standardization
Market Opportunities
Expanding Single-Cell Multiomics Applications

Chapter 4 Emerging Technologies and Developments

Artificial Intelligence in Multiomics
Companies in the Artificial Intelligence Multiomics Market
Advances in Single-Cell Omics and Multiomics

Chapter 5 Market Segmentation Analysis

Key Market Trends
Segmentation Breakdown
Global Market for Multiomics by Product
Instruments
Consumables
Software and Services
Global Market for Multiomics by Platform
Genomics
Proteomics
Transcriptomics
Metabolomics
Other Platforms
Global Market for Multiomics by Application
Oncology
Immunology
Neurology
Cell Biology
Other Applications
Global Market for Multiomics by End User
Academic Research Organizations
Pharmaceutical and Biotechnology Companies
Clinical and Hospital Laboratories
Other End Users
Geographic Breakdown
Global Multiomics Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Top Players Ranking
Key Strategies Adopted by Players
Collaborations and Partnerships
New Product Launches
Expansions and Investments
Mergers and Acquisitions
Agreements
Patent Analysis

Chapter 7 Sustainability in Multiomics Market: ESG Perspective

Introduction to ESG
ESG Performance in Market
ESG Practices in the Multiomics Industry
Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology
Acronyms
References
Company Profiles
AGILENT TECHNOLOGIES INC.
BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIO-RAD LABORATORIES INC.
BD
BRUKER
BGI
F. HOFFMANN-LA ROCHE LTD.
ILLUMINA INC.
QIAGEN
REVVITY
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.

簡介目錄圖表

List of Tables

Summary Table A : Global Market for Multiomics, by Product, Through 2029
Summary Table B : Global Market for Multiomics, by Region, Through 2029
Table 1 : Multiomics Approaches and Their Molecular Readouts
Table 2 : Molecular Biology Technologies for Multiomics Approaches
Table 3 : Single-Cell and Spatial Omics Technologies, 2018-2023
Table 4 : Publicly Available Omics Data in the Cancer Research Field
Table 5 : Multiomics' Role During Various Stages of Drug Development Process
Table 6 : Companies in the Artificial Intelligence Multiomics Market
Table 7 : Global Market for Multiomics, by Product, Through 2029
Table 8 : Global Market for Multiomics for Instruments, by Region, Through 2029
Table 9 : Global Market for Multiomics for Consumables, by Region, Through 2029
Table 10 : Global Market for Multiomics for Software and Services, by Region, Through 2029
Table 11 : Global Market for Multiomics, by Platform, Through 2029
Table 12 : Global Market for Multiomics for Genomics, by Region, Through 2029
Table 13 : Global Market for Multiomics for Proteomics, by Region, Through 2029
Table 14 : Global Market for Multiomics for Transcriptomics, by Region, Through 2029
Table 15 : Global Market for Multiomics for Metabolomics, by Region, Through 2029
Table 16 : Global Market for Multiomics for Other Platforms, by Region, Through 2029
Table 17 : Global Market for Multiomics, by Application, Through 2029
Table 18 : Global Market for Multiomics for Oncology, by Region, Through 2029
Table 19 : Global Market for Multiomics for Immunology, by Region, Through 2029
Table 20 : Global Market for Multiomics for Neurology, by Region, Through 2029
Table 21 : Global Market for Multiomics for Cell Biology, by Region, Through 2029
Table 22 : Global Market for Multiomics for Other Applications, by Region, Through 2029
Table 23 : Global Market for Multiomics, by End User, Through 2029
Table 24 : Global Market for Multiomics for Academic Research Organizations, by Region, Through 2029
Table 25 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, Through 2029
Table 26 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, Through 2029
Table 27 : Global Market for Multiomics for Other End Users, by Region, Through 2029
Table 28 : Global Market for Multiomics, by Region, Through 2029
Table 29 : North American Market for Multiomics, by Product, Through 2029
Table 30 : North American Market for Multiomics, by Platform, Through 2029
Table 31 : North American Market for Multiomics, by Application, Through 2029
Table 32 : North American Market for Multiomics, by End User, Through 2029
Table 33 : European Initiatives Focused on Omics Research for Personalized Medicine
Table 34 : European Market for Multiomics, by Product, Through 2029
Table 35 : European Market for Multiomics, by Platform, Through 2029
Table 36 : European Market for Multiomics, by Application, Through 2029
Table 37 : European Market for Multiomics, by End User, Through 2029
Table 38 : Asia-Pacific Market for Multiomics, by Product, Through 2029
Table 39 : Asia-Pacific Market for Multiomics, by Platform, Through 2029
Table 40 : Asia-Pacific Market for Multiomics, by Application, Through 2029
Table 41 : Asia-Pacific Market for Multiomics, by End User, Through 2029
Table 42 : Rest of the World Market for Multiomics, by Product, Through 2029
Table 43 : Rest of the World Market for Multiomics, by Platform, Through 2029
Table 44 : Rest of the World Market for Multiomics, by Application, Through 2029
Table 45 : Rest of the World Market for Multiomics, by End User, Through 2029
Table 46 : Top Players in Multiomics Market, 2023
Table 47 : Collaborations and Partnerships: Multiomics Market, 2021-2024
Table 48 : New Product Launches: Multiomics Market, 2021-2024
Table 49 : Expansions and Investments: Multiomics Market, 2021-2024
Table 50 : Mergers and Acquisitions: Multiomics Market, 2020-2024
Table 51 : Agreements: Multiomics Market, 2022-2024
Table 52 : Multiomics Market: Patent Analysis, 2018-2023
Table 53 : Key Focus Areas in ESG Metrics
Table 54 : Environmental Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 55 : Social Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 56 : Governance Performance Initiatives in the Multiomics Market, 2022 and 2023
Table 57 : ESG Rankings for Multiomics Companies, 2024*
Table 58 : Acronyms Used in this Report
Table 59 : Agilent Technologies Inc.: Company Snapshot
Table 60 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Agilent Technologies Inc.: Product Portfolio
Table 62 : Agilent Technologies Inc.: News/Key Developments, 2023
Table 63 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Company Snapshot
Table 64 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): Product Portfolio
Table 65 : Beckman Coulter Inc. (Subsidiary of Danaher Corp.): News/Key Developments, 2023
Table 66 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 67 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 68 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 69 : Bio-Rad Laboratories Inc.: News/Key Developments, 2020
Table 70 : BD: Company Snapshot
Table 71 : BD: Financial Performance, FY 2022 and 2023
Table 72 : BD: Product Portfolio
Table 73 : BD: News/Key Developments, 2024
Table 74 : Bruker: Company Snapshot
Table 75 : Bruker: Financial Performance, FY 2022 and 2023
Table 76 : Bruker: Product Portfolio
Table 77 : Bruker: News/Key Developments, 2024
Table 78 : BGI: Company Snapshot
Table 79 : BGI: Product Portfolio
Table 80 : BGI: News/Key Developments, 2024
Table 81 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 82 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 83 : F. Hoffman-La Roche Ltd.: Product Portfolio
Table 84 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2022
Table 85 : Illumina Inc.: Company Snapshot
Table 86 : Illumina Inc.: Financial Performance, FY 2022 and 2023
Table 87 : Illumina Inc.: Product Portfolio
Table 88 : Illumina Inc.: News/Key Developments, 2023
Table 89 : QIAGEN: Company Snapshot
Table 90 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 91 : QIAGEN: Product Portfolio
Table 92 : QIAGEN: News/Key Developments, 2024
Table 93 : Revvity: Company Snapshot
Table 94 : Revvity: Financial Performance, FY 2022 and 2023
Table 95 : Revvity: Product Portfolio
Table 96 : Revvity: News/Key Developments, 2023
Table 97 : Standard BioTools: Company Snapshot
Table 98 : Standard BioTools: Financial Performance, FY 2022 and 2023
Table 99 : Standard BioTools: Product Portfolio
Table 100 : Standard BioTools: News/Key Developments, 2024
Table 101 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 102 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 103 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 104 : Thermo Fisher Scientific Inc.: News/Key Developments, 2024

List of Figures

Summary Figure A : Global Market for Multiomics, by Product, 2021-2029
Summary Figure B : Global Market for Multiomics, by Region, 2021-2029
Figure 1 : Omics Types
Figure 2 : Applications of Multiomics Approaches
Figure 3 : PESTEL Analysis: Multiomics Market
Figure 4 : Strategic Recommendations: Multiomics Market
Figure 5 : Multiomics Market Dynamics
Figure 6 : Average Cost Per Genome: Year-on-Year Trend, 2011-2022
Figure 7 : Global Market Shares for Multiomics, by Product, 2024
Figure 8 : Global Market for Multiomics for Instruments, by Region, 2021-2029
Figure 9 : Global Market for Multiomics for Consumables, by Region, 2021-2029
Figure 10 : Global Market for Multiomics for Software and Services, by Region, 2021-2029
Figure 11 : Global Market Shares for Multiomics, by Platform, 2024
Figure 12 : Global Market for Multiomics for Genomics, by Region, 2021-2029
Figure 13 : Global Market for Multiomics for Proteomics, by Region, 2021-2029
Figure 14 : Global Market for Multiomics for Transcriptomics, by Region, 2021-2029
Figure 15 : Global Market for Multiomics for Metabolomics, by Region, 2021-2029
Figure 16 : Global Market for Multiomics for Other Platforms, by Region, 2021-2029
Figure 17 : Major Applications of Multiomics
Figure 18 : Global Market Shares for Multiomics, by Application, 2024
Figure 19 : Global Market for Multiomics for Oncology, by Region, 2021-2029
Figure 20 : Global Market for Multiomics for Immunology, by Region, 2021-2029
Figure 21 : Global Market for Multiomics for Neurology, by Region, 2021-2029
Figure 22 : Global Market for Multiomics for Cell Biology, by Region, 2021-2029
Figure 23 : Global Market for Multiomics for Other Applications, by Region, 2021-2029
Figure 24 : Global Market Shares for Multiomics, by End User, 2024
Figure 25 : Global Market for Multiomics for Academic Research Organizations, by Region, 2021¬-2029
Figure 26 : Global Market for Multiomics for Pharmaceutical and Biotechnology Companies, by Region, 2021-2029
Figure 27 : Global Market for Multiomics for Clinical and Hospital Laboratories, by Region, 2021-2029
Figure 28 : Global Market for Multiomics for Other End Users, by Region, 2021-2029
Figure 29 : Global Market Shares of Multiomics, by Region, 2024
Figure 30 : North American Market for Multiomics, by Product, 2021-2029
Figure 31 : North American Market for Multiomics, by Platform, 2021-2029
Figure 32 : North American Market for Multiomics, by Application, 2021-2029
Figure 33 : North American Market for Multiomics, by End User, 2021-2029
Figure 34 : European Market for Multiomics, by Product, 2021-2029
Figure 35 : European Market for Multiomics, by Platform, 2021-2029
Figure 36 : European Market for Multiomics, by Application, 2021-2029
Figure 37 : European Market for Multiomics, by End User, 2021-2029
Figure 38 : Asia-Pacific Multiomics Market Growth Drivers
Figure 39 : Asia-Pacific Market for Multiomics, by Product, 2021-2029
Figure 40 : Asia-Pacific Market for Multiomics, by Platform, 2021-2029
Figure 41 : Asia-Pacific Market for Multiomics, by Application, 2021-2029
Figure 42 : Asia-Pacific Market for Multiomics, by End User, 2021-2029
Figure 43 : Rest of the World Market for Multiomics, by Product, 2021-2029
Figure 44 : Rest of the World Market for Multiomics, by Platform, 2021-2029
Figure 45 : Rest of the World Market for Multiomics, by Application, 2021-2029
Figure 46 : Rest of the World Market for Multiomics, by End User, 2021-2029
Figure 47 : Global Multiomics Market Competitive Intelligence, 2020-2024
Figure 48 : Patents, 2018-2023
Figure 49 : How a Strong ESG Proposition Benefits Businesses
Figure 50 : Biotech Companies Providing ESG Disclosure, 2022
Figure 51 : Location of ESG Disclosure, 2022
Figure 52 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 53 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 54 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 55 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 56 : BD: Revenue Share, by Business Unit, FY 2023
Figure 57 : BD: Revenue Share, by Country/Region, FY 2023
Figure 58 : Bruker: Revenue Share, by Business Unit, FY 2023
Figure 59 : Bruker: Revenue Share, by Country/Region, FY 2023
Figure 60 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 61 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
Figure 64 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 65 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 66 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 67 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 68 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
Figure 69 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
Figure 70 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 71 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023